- Home
- Shop
- New Categories
- New Blog
- Contact Us
- Cart
- Login
- Register
Select the image to view it full size.
Product details
Catalog number 133000-22-32.1G
Price for 133000-22-32.1G
Size / count 1 g
PEG crosslinkers with Fmoc (fluorenylmethoxycarbonyl) -protected amino groups on one chain end. The Fmoc protecting group is stable in a wide range of conditions (including highly acidic environments) . It may be easily removed by primary and secondary amine bases (such as piperidine) in polar solvents to release the primary amine which allows for selective and covalent attachment to other molecules with complementary functional groups, such as carboxylic acids or activated esters, aldehydes and epoxides. Applicable for reversible or permanent crosslinking with PEG. The butyric acid endgroup is directly connected to the PEG chain via a very stable ether linkage. After activation it is used to conjugate the PEG derivative to nucleophilic substrates, mainly amines (to form amides) or hydroxyls/thiols (forming esters/thioesters) .
The catalog number for Ɑ-Butyric Acid-ω-Fmoc Amino PEG is 133000-22-32.1G.
Ɑ-Butyric Acid-ω-Fmoc Amino PEG is available in the following size(s): 1 g.
Ɑ-Butyric Acid-ω-Fmoc Amino PEG is currently made to order / not held in immediate stock. Contact us for lead time.
PEG crosslinkers with Fmoc (fluorenylmethoxycarbonyl) -protected amino groups on one chain end. The Fmoc protecting group is stable in a wide range of conditions (including highly acidic environments) . It may be easily removed by primary and secondary amine bases (such as piperidine) in polar solve
Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.
Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
